norethindrone has been researched along with Osteoporosis in 33 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 22 (66.67) | 18.7374 |
| 1990's | 6 (18.18) | 18.2507 |
| 2000's | 3 (9.09) | 29.6817 |
| 2010's | 2 (6.06) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chwalisz, K; Stanczyk, FZ; Surrey, E | 1 |
| Kaore, SN; Langade, DK; Sharma, P; Sharma, R; Thawani, VR; Yadav, VK | 1 |
| Cetin, A; Dane, B; Dane, C; Erginbas, M | 1 |
| Ambrus, CM; Ambrus, JL; Robin, JC | 1 |
| Christiansen, C; Riis, BJ | 2 |
| Christiansen, C; Rødbro, P; Tjellesen, L | 1 |
| Gordan, GS | 1 |
| Christiansen, C; Rødbro, P | 2 |
| Christensen, MS; Christiansen, C; Hagen, C; Rødbro, P; Transbøl, I | 1 |
| Christiansen, C; Jensen, GF; Transbøl, I | 1 |
| Crilly, RG; Horsman, A; Marshall, DH; Nordin, BE; Simpson, M | 1 |
| Casper, RF; Chachra, D; Grynpas, MD; Kasra, M; MacLusky, NJ; Vanin, CM | 1 |
| Riggs, BL | 1 |
| Holland, EF; Leather, AT; Studd, JW; Watson, NR | 1 |
| Schreiber, V; Stĕpán, JJ | 1 |
| Aisaka, K | 1 |
| Alexandersen, P; Bjarnason, NH; Christiansen, C | 1 |
| Gallagher, JC; Guha, P; Hanes, F; Marshall, DH; Nordin, BE; Oldfield, W | 1 |
| Cust, MP; Gangar, KF; Hillard, TC; Lees, B; Stevenson, JC; Whitehead, MI | 1 |
| Christiansen, C; Jacobson, J; Johansen, JS; Riis, BJ | 1 |
| Hemp, O; Löttge, M; Seifert, B; Spieler, W | 1 |
| Christiansen, C; Deftos, L; Nilas, L; Riis, BJ; Rødbro, P | 1 |
| Christiansen, C; Johansen, J; Riis, BJ | 1 |
| Gambrell, RD | 1 |
| Chatterton, BE; Horowitz, M; Need, AG; Nordin, BE; Steurer, TA; Walker, CJ | 1 |
| Francis, RM; Selby, PL | 1 |
| Christiansen, C | 1 |
| Christiansen, C; Jensen, J; Rødbro, P | 1 |
| Abdalla, HI; Hart, DM; Hooke, A; Leggate, I; Lindsay, R | 1 |
| Zussman, L | 1 |
7 review(s) available for norethindrone and Osteoporosis
| Article | Year |
|---|---|
The hormonal profile of norethindrone acetate: rationale for add-back therapy with gonadotropin-releasing hormone agonists in women with endometriosis.
Topics: Bone Density; Endometriosis; Estrogens; Female; Gonadotropin-Releasing Hormone; Hot Flashes; Humans; Lipoproteins, HDL; Norethindrone; Norethindrone Acetate; Osteoporosis; Pelvic Pain; Progesterone | 2012 |
Novel actions of progesterone: what we know today and what will be the scenario in the future?
Topics: Animals; Brain Diseases; Brain Injuries; Contraceptive Agents, Male; Female; Humans; Male; Megestrol Acetate; Norethindrone; Osteoporosis; Progesterone; Progestins; Prostatic Hyperplasia; Prostatic Neoplasms | 2012 |
Prevention of bone loss and fractures in women.
Topics: Age Factors; Aged; Bone and Bones; Calcium; Estrogens; Female; Fractures, Spontaneous; Humans; Menopause; Middle Aged; Norethindrone; Organ Size; Osteoporosis; Phosphorus; Racial Groups; Sex Factors; Uterine Neoplasms | 1984 |
Formation-stimulating regimens other than sodium fluoride.
Topics: Anabolic Agents; Calcitriol; Diphosphonates; Growth Hormone; Humans; Insulin-Like Growth Factor I; Norethindrone; Norethindrone Acetate; Osteogenesis; Osteoporosis; Parathyroid Hormone; Peptide Fragments; Progesterone Congeners; Teriparatide | 1993 |
[Add back therapy for patients with endometriosis].
Topics: Drug Administration Schedule; Drug Combinations; Endometriosis; Estrogen Replacement Therapy; Female; Gonadotropin-Releasing Hormone; Humans; Mestranol; Norethindrone; Osteoporosis | 2001 |
The menopause.
Topics: Adult; Breast Neoplasms; Calcium; Clinical Trials as Topic; Coronary Disease; Estrogens; Female; Gallbladder Diseases; Humans; Lipid Metabolism; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis; Thromboembolism; Uterine Neoplasms | 1986 |
Post-menopausal bone loss: effects of oestrogens and progestogens. A review.
Topics: Drug Therapy, Combination; Estradiol; Estrogens; Female; Humans; Norethindrone; Norethindrone Acetate; Osteoporosis; Progestins | 1986 |
16 trial(s) available for norethindrone and Osteoporosis
| Article | Year |
|---|---|
Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis.
Topics: Bone Density; Bone Density Conservation Agents; Collagen Type I; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Female; Humans; Norethindrone; Osteocalcin; Osteoporosis; Peptides; Postmenopause; Raloxifene Hydrochloride | 2007 |
Does calcium potentiate the bone-preserving effect of oestrogen treatment in early post-menopausal women by a change in vitamin D metabolism?
Topics: Calcium; Clinical Trials as Topic; Drug Combinations; Drug Therapy, Combination; Estradiol; Estriol; Female; Humans; Hydroxycholecalciferols; Menopause; Middle Aged; Norethindrone; Osteoporosis | 1984 |
Serum alkaline phosphatase during hormone treatment in early postmenopausal women. A model for establishing optimal prophylaxis and treatment in postmenopausal osteoporosis.
Topics: Adult; Aged; Alkaline Phosphatase; Bone and Bones; Clinical Trials as Topic; Estradiol; Estriol; Estrogens; Female; Humans; Hydroxyproline; Menopause; Middle Aged; Minerals; Norethindrone; Osteoporosis | 1984 |
Does oestriol add to the beneficial effect of combined hormonal prophylaxis against early postmenopausal osteoporosis?
Topics: Calcium; Coronary Disease; Drug Therapy, Combination; Estradiol; Estriol; Female; Hormones; Humans; Menopause; Norethindrone; Osteoporosis; Risk | 1984 |
Effect of 1,25-dihydroxy-vitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis.
Topics: Bone and Bones; Calcitriol; Calcium; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Estradiol; Estriol; Estrogens; Female; Humans; Menopause; Middle Aged; Minerals; Norethindrone; Norethindrone Acetate; Osteoporosis; Phosphates; Progestins | 1981 |
Treatment of post menopausal osteoporosis. A controlled therapeutic trial comparing oestrogen/gestagen, 1,25-dihydroxy-vitamin D3 and calcium.
Topics: Aged; Bone and Bones; Calcitriol; Calcium; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Estradiol; Estriol; Female; Humans; Menopause; Norethindrone; Norethindrone Acetate; Osteoporosis | 1982 |
The prevention of bone loss in young women treated with GnRH analogues with "add-back" estrogen therapy.
Topics: Administration, Oral; Adult; Bone Density; Double-Blind Method; Drug Implants; Estradiol; Estrogens; Female; Goserelin; Humans; Middle Aged; Norethindrone; Osteoporosis; Premenstrual Syndrome | 1993 |
Number of years since menopause: spontaneous bone loss is dependent but response to hormone replacement therapy is independent.
Topics: Age Factors; Bone Density; Cross-Sectional Studies; Estradiol; Estrogen Replacement Therapy; Female; Humans; Longitudinal Studies; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norpregnenes; Osteoporosis; Progesterone Congeners | 2002 |
The effect of 1alpha-hydroxycholecalciferol and hormone therapy on the calcium balance of post-menopausal osteoporosis.
Topics: Bone and Bones; Bone Regeneration; Bone Resorption; Calcium; Clinical Trials as Topic; Ethinyl Estradiol; Female; Humans; Hydroxycholecalciferols; Hydroxyproline; Intestinal Absorption; Menopause; Norethindrone; Osteoporosis; Surgery, Plastic | 1977 |
Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women.
Topics: Absorptiometry, Photon; Administration, Cutaneous; Administration, Oral; Bone Density; Drug Administration Schedule; Drug Combinations; Drug Evaluation; Estradiol; Estradiol Congeners; Estrogen Replacement Therapy; Female; Femur Head; Humans; Lumbar Vertebrae; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Osteoporosis; Randomized Controlled Trials as Topic; Time Factors | 1990 |
Uncoupling of bone formation and resorption by combined oestrogen and progestagen therapy in postmenopausal osteoporosis.
Topics: Bone Development; Bone Resorption; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Estriol; Estrogens; Female; Humans; Menopause; Middle Aged; Norethindrone; Osteoporosis; Progestins | 1985 |
Continuous oestrogen-progestogen treatment and bone metabolism in post-menopausal women.
Topics: Alkaline Phosphatase; Biochemical Phenomena; Biochemistry; Bone and Bones; Calcium; Calcium-Binding Proteins; Clinical Trials as Topic; Creatinine; Double-Blind Method; Drug Combinations; Estradiol; Female; Humans; Hydroxyproline; Menopause; Middle Aged; Minerals; Norethindrone; Norethindrone Acetate; Osteocalcin; Osteoporosis; Radionuclide Imaging; Random Allocation | 1988 |
The menopause.
Topics: Adult; Breast Neoplasms; Calcium; Clinical Trials as Topic; Coronary Disease; Estrogens; Female; Gallbladder Diseases; Humans; Lipid Metabolism; Menopause; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis; Thromboembolism; Uterine Neoplasms | 1986 |
Photon absorptiometry studies in osteoporosis.
Topics: Bone and Bones; Calcitriol; Calcium; Clinical Trials as Topic; Drug Combinations; Estradiol; Estriol; Female; Fluorides; Humans; Hydroxycholecalciferols; Menopause; Middle Aged; Minerals; Norethindrone; Osteoporosis; Radionuclide Imaging; Vitamin D | 1985 |
Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause.
Topics: Adult; Bone Resorption; Drug Combinations; Estradiol; Estriol; Estrogens; Estrone; Female; Humans; Menopause; Middle Aged; Norethindrone; Osteoporosis; Smoking | 1985 |
Prevention of bone mineral loss in postmenopausal women by norethisterone.
Topics: Alkaline Phosphatase; Bone and Bones; Calcium; Creatinine; Drug Evaluation; Female; Humans; Hydroxyproline; Kidney Tubules; Menopause; Middle Aged; Minerals; Norethindrone; Osteoporosis; Phosphates; Time Factors | 1985 |
11 other study(ies) available for norethindrone and Osteoporosis
| Article | Year |
|---|---|
Studies on osteoporosis X. Effect of estrogen-progestin combination on heparin-induced osteoporosis.
Topics: Animals; Calcium; Drug Therapy, Combination; Estrogens; Estrogens, Conjugated (USP); Female; Heparin; Mice; Mice, Inbred C3H; Norethindrone; Osteoporosis; Progestins | 1983 |
Does postmenopausal bone loss respond to estrogen replacement therapy independent of bone loss rate?
Topics: Aged; Bone and Bones; Drug Therapy, Combination; Estradiol; Estradiol Congeners; Estriol; Female; Follow-Up Studies; Humans; Menopause; Middle Aged; Minerals; Norethindrone; Norethindrone Acetate; Osteoporosis | 1983 |
Treatment of spinal osteoporosis in postmenopausal women.
Topics: Aged; Calcium; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hydroxycholecalciferols; Menopause; Middle Aged; Norethindrone; Osteoporosis; Spinal Diseases; Vitamin D | 1980 |
The effect of different hormone replacement therapy regimens on the mechanical properties of rat vertebrae.
Topics: Animals; Biomechanical Phenomena; Bone Density; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Female; Lumbar Vertebrae; Norethindrone; Osteoporosis; Ovariectomy; Rats; Rats, Sprague-Dawley; Stress, Mechanical | 1995 |
Anabolic effects of progestogens in bone remodelling.
Topics: Alkaline Phosphatase; Bone and Bones; Bone Density; Bone Remodeling; Estradiol; Female; Follow-Up Studies; Humans; Hydroxyproline; Norethindrone; Norpregnenes; Osteoporosis; Ovariectomy; Progestins; Prospective Studies | 1995 |
Vitamin-D analogues and renal function.
Topics: Aged; Calcium; Creatinine; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Hydroxycholecalciferols; Hypercalcemia; Kidney; Menopause; Middle Aged; Norethindrone; Osteoporosis; Uremia | 1978 |
Is it possible to prevent bone loss in young women treated with luteinizing hormone-releasing hormone agonists?
Topics: Adult; Bone and Bones; Bone Density; Calcium; Drug Therapy, Combination; Endometriosis; Estradiol; Female; Gonadotropin-Releasing Hormone; Humans; Lipid Metabolism; Lipoproteins; Nafarelin; Norethindrone; Osteoporosis | 1990 |
[Interdisciplinary diagnosis and therapy concepts in climacteric osteoporosis].
Topics: Adult; Bone and Bones; Calcium; Chlormadinone Acetate; Climacteric; Combined Modality Therapy; Ethinyl Estradiol; Female; Fluorides; Follow-Up Studies; Humans; Middle Aged; Norethindrone; Norethindrone Acetate; Osteoporosis; Physical Therapy Modalities; Radiography | 1989 |
Comparison of calcium, calcitriol, ovarian hormones and nandrolone in the treatment of osteoporosis.
Topics: Aged; Calcitriol; Calcium; Female; Humans; Middle Aged; Nandrolone; Norethindrone; Osteoporosis | 1986 |
Norethisterone in postmenopausal osteoporosis.
Topics: Calcium; Female; Humans; Menopause; Norethindrone; Osteoporosis | 1987 |
The climacteric.
Topics: Adolescent; Adult; Age Factors; Aged; Blood Pressure; Castration; Climacteric; Endometrial Hyperplasia; Estradiol; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Hysterectomy; Libido; Male; Medroxyprogesterone; Menopause; Methyltestosterone; Middle Aged; Norethindrone; Osteoporosis; Progesterone | 1973 |